{"id":372613,"title":"Health Product InfoWatch: October 2022 - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T17:22:30.584000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/october-2022.html","snippet":"Health Product InfoWatch: October 2022 Contents Health products mentioned in this issue Coronavirus disease (COVID-19) Drug and vaccine authorizations and communications for COVID-19 Actemra (tocilizumab) Comirnaty Original & Omicron BA.4/BA.5 Bivalent Vaccine (COVID-19 mRNA…","rawSnapshotUrl":"/api/snapshots/raw/372613","browseUrl":"https://replay.healtharchive.ca/job-6/20260411172230/https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/october-2022.html#ha_snapshot=372613","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}